pirin and extended-release dipyridamole versus clopidogrel for
recurrent stroke. N Engl J Med 2008;359:1238-51.
134. Zhang JJ, Liu X. Aspirin plus dipyridamole has the highest surface
under the cumulative ranking curves (SUCRA) values in terms of
mortality, intracranial hemorrhage, and adverse event rate among 7
drug therapies in the treatment of cerebral infarction. Medicine
(Baltimore) 2018;97:e0123.
135. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel
with aspirin in acute minor stroke or transient ischemic attack.
N Engl J Med 2013;369:11-9.
136. Wong KS, Wang Y, Leng X, Mao C, Tang J, Bath PM, et al. Early dual
versus mono antiplatelet therapy for acute non-cardioembolic
ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation 2013;128:1656-66.
137. Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, et al. Aspirin plus
clopidogrel as secondary prevention after stroke or transient
ischemic attack: a systematic review and meta-analysis. Cerebrovasc Dis 2015;39:13-22.
138. Niu PP, Guo ZN, Jin H, Xing YQ, Yang Y. Antiplatelet regimens in the
long-term secondary prevention of transient ischaemic attack and
ischaemic stroke: an updated network meta-analysis. BMJ Open
2016;6:e009013.
139. Lennard N, Smith JL, Hayes P, Evans DH, Abbott RJ, London NJ, et al.
Transcranial Doppler directed dextran therapy in the prevention of
carotid thrombosis: three hour monitoring is as effective as six
hours. Eur J Vasc Endovasc Surg 1999;17:3